STIM

STIM

USD

Neuronetics Inc. Common Stock

$2.870+0.490 (20.588%)

Цена в режиме реального времени

Healthcare
Медицинские приборы
Соединенные Штаты

График цен

Loading Chart...

Ключевые показатели

Рыночные показатели
Фундаментальные показатели компании
Статистические данные торговли

Рыночные показатели

Открытие

$2.380

Максимум

$3.090

Минимум

$2.380

Объем

0.12M

Фундаментальные показатели компании

Рыночная капитализация

189.8M

Отрасль

Медицинские приборы

Страна

United States

Статистические данные торговли

Средний объем

1.33M

Биржа

NGM

Валюта

USD

52-недельный диапазон

Минимум $0.52Текущая $2.870Максимум $5.92

Связанные новости

GlobeNewswire

Neuronetics Reports Third Quarter 2025 Financial and Operating Results and Announces CEO Transition Plan

Delivered $37.3 million total revenue in Q3 2025, representing 11% adjusted pro forma revenue growth versus Q3 2024 Generated Greenbrook clinic revenue of $21.8 million in Q3 2025, an increase of 25% on an adjusted

Просмотреть больше
Neuronetics Reports Third Quarter 2025 Financial and Operating Results and Announces CEO Transition Plan
GlobeNewswire

Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

MALVERN, Pa., Oct. 31, 2025 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ:STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve the quality of life

Просмотреть больше
Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire

Neuronetics Announces Three-Year Exclusive Partnership with Elite DNA Behavioral Health to Expand NeuroStar Access and Operational Excellence

MALVERN, Pa., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ:STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who

Просмотреть больше
Neuronetics Announces Three-Year Exclusive Partnership with Elite DNA Behavioral Health to Expand NeuroStar Access and Operational Excellence
GlobeNewswire

Neuronetics to Report Third Quarter 2025 Financial and Operating Results and Host Conference Call

MALVERN, Pa., Oct. 21, 2025 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ:STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who

Просмотреть больше
Neuronetics to Report Third Quarter 2025 Financial and Operating Results and Host Conference Call

Оставаться в курсе

Установите ценовой сигнал, получите обновления анализа ИИ и новости рынка в режиме реального времени.